Frequency of Administration of Erythropoiesis-Stimulating Agents for the Anaemia of End-Stage Kidney Disease in Dialysis

被引：0
|
作者：
Webster, Angela
机构：
来源：
NEPHROLOGY | 2015年 / 20卷 / 09期
关键词：
D O I：
10.1111/nep.12438
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：663 / 665
页数：3
相关论文
共 50 条
  • [1] Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients
    Hahn, Deirdre
    Cody, June D.
    Hodson, Elisabeth M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
  • [2] Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
    Minutolo, Roberto
    Garofalo, Carlo
    Chiodini, Paolo
    Aucella, Filippo
    Del Vecchio, Lucia
    Locatelli, Francesco
    Scaglione, Francesco
    De Nicola, Luca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (02) : 267 - 274
  • [3] Safety of erythropoiesis-stimulating agents in patients with end-stage kidney disease: data are safer than extrapolations
    Abraham, Ivo
    MacDonald, Karen
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (06) : 885 - 887
  • [4] Erythropoiesis-stimulating agents for anaemia in chronic kidney disease: are they all the same?
    Mudge, David W.
    Webster, Angela C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [5] Erythropoiesis-stimulating agents: Treating the anaemia of chronic kidney disease - Foreword
    Carrera, Fernando
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 1 - 1
  • [6] Erythropoiesis-stimulating agents and incident malignancy in chronic kidney and end-stage renal disease: A population-based study
    Huang, Yu-Shan
    Li, Ming-Feng
    Lin, Mei-Chen
    Ou, Shih-Hsiang
    Wang, Jen-Hung
    Huang, Chien-Wei
    Chou, Kang-Ju
    Fang, Hua-Chang
    Lee, Po-Tsang
    Hsu, Chih-Yang
    Chen, Jin-Shuen
    Chen, Hsin-Yu
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (09): : 2195 - 2205
  • [7] Erythropoiesis-Stimulating Agent Hyporesponsiveness in End-Stage Renal Disease Patients
    Ogawa, Tetsuya
    Nitta, Kosaku
    CHRONIC KIDNEY DISEASES - RECENT ADVANCES IN CLINICAL AND BASIC RESEARCH, 2015, 185 : 76 - 86
  • [8] Erythropoiesis-stimulating agents in kidney and cardiac disease
    Fluck, Richard
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (10) : 533 - 537
  • [9] MECHANISMS OF HEMOGLOBIN CYCLING IN ANEMIC END-STAGE RENAL DISEASE PATIENTS TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS
    Joerg, David
    Fuertinger, Doris
    Kotanko, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I609 - I609
  • [10] Equipotent Doses of Erythropoiesis-Stimulating Agents in Outpatients with Anaemia Secondary to Chronic Kidney Disease
    Escudero-Vilaplana, Vicente
    Martinez-Nieto, Concepcion
    Manuel Lopez-Gomez, Juan
    Vega-Martinez, Almudena
    Sanjurjo-Saez, Maria
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (03): : 454 - 458
12345